Literature DB >> 16736413

Systolic and diastolic function in renal replacement therapy: a cross-sectional study.

Giovambattista Virga1, Berardino Stomaci, Alessandra Munaro, Stefania Mastrosimone, Marilena Cara, Elisabetta Artuso, Piergiuseppe Piovesana.   

Abstract

BACKGROUND: Heart disease is the main cause of death among uremic patients (pts). Our study aimed to assess left ventricular (LV) systolic and diastolic function in all of our pts on renal replacement therapy (RRT), investigating any differences between hemodialysis (HD), peritoneal dialysis (PD) and transplantation (TX) pts.
METHODS: All pts on RRT at our nephrology unit were enrolled in the study and evaluated once over a period of 6 months: 125 pts were studied: 61 pts on HD, 30 pts on PD and 34 TX pts. Systolic and diastolic function indexes were compared between HD, PD and TX pts. All comparisons were corrected for the effects of age, gender and time on treatment.
RESULTS: HD pts suffered from worse systolic function, with a lower mean fractional shortening and ejection fraction (EF), than TX pts. Twenty percent of HD pts had an EF value <55%. PD pts showed worse diastolic function than TX pts and >80% of them suffered from pathological diastolic indexes. The proportion of hypertensive pts was TX 88.2%, PD 86.7% and HD 50.8%. The percentage of pts with LV hypertrophy (LVH) was TX 55.9%, PD 53.3% and HD 36.1%.
CONCLUSIONS: TX pts had better systolic and diastolic function than HD and PD pts, despite having more hypertension and LVH.

Entities:  

Mesh:

Year:  2006        PMID: 16736413

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  6 in total

1.  Blood pressure profile in renal transplant recipients and its relation to diastolic function: tissue Doppler echocardiographic study.

Authors:  Mitra Basiratnia; Maryam Esteghamati; Gholam Hossein Ajami; Hamid Amoozgar; Cyrus Cheriki; Manoochehr Soltani; Ali Derakhshan; Mohammad Hossein Fallahzadeh
Journal:  Pediatr Nephrol       Date:  2011-01-04       Impact factor: 3.714

Review 2.  Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease.

Authors:  David Charytan
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-11       Impact factor: 2.894

3.  Age-related blood pressure patterns and blood pressure variability among hemodialysis patients.

Authors:  Mark R Rohrscheib; Orrin B Myers; Karen S Servilla; Christopher D Adams; Dana Miskulin; Edward J Bedrick; William C Hunt; Douglas E Lindsey; Darlene Gabaldon; Philip G Zager
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-13       Impact factor: 8.237

Review 4.  Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome.

Authors:  Suzan Willemsen; Jasper W L Hartog; M Rebecca Heiner-Fokkema; Dirk J van Veldhuisen; Adriaan A Voors
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 5.  Hypertension in the Pediatric Kidney Transplant Recipient.

Authors:  Olga Charnaya; Asha Moudgil
Journal:  Front Pediatr       Date:  2017-05-01       Impact factor: 3.418

6.  Prevalence and Outcomes of Left-Sided Valvular Heart Disease Associated With Chronic Kidney Disease.

Authors:  Zainab Samad; Joseph A Sivak; Matthew Phelan; Phillip J Schulte; Uptal Patel; Eric J Velazquez
Journal:  J Am Heart Assoc       Date:  2017-10-11       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.